USA Financial Formulas’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-260
Closed -$51K 394
2020
Q4
$51K Buy
+260
New +$45.9K 0.04% 178
2019
Q1
Sell
-1,443
Closed -$320K 252
2018
Q4
$320K Sell
1,443
-554
-28% -$94.8K 0.08% 214
2018
Q3
$320K Buy
1,997
+597
+43% +$121K 0.08% 208
2018
Q2
$131K Hold
1,400
0.03% 284
2018
Q1
$131K Buy
+1,400
New +$105K 0.03% 284

Other funds holding MED

USA Financial Formulas's MED Position: Q1 2021 in Review

USA Financial Formulas sold out of Medifast (MED) in Q1 2021, closing a stake of 260 shares — an estimated $51K sold.

USA Financial Formulas first reported a position in MED in Q1 2018 and held it in 5 quarters. The position peaked at $320K in Q4 2018. 277 funds tracked by Wall St. Rank hold MED as of Q1 2021.

  • USA Financial Formulas reported no remaining Medifast position as of Q1 2021 after selling out during the quarter.
  • USA Financial Formulas sold 260 Medifast shares in Q1 2021, an estimated $51K.
  • USA Financial Formulas first reported a position in Medifast in Q1 2018 and held it in 5 quarters.
  • USA Financial Formulas's Medifast position peaked at $320K in Q4 2018.
  • 277 funds tracked by Wall St. Rank held Medifast as of Q1 2021.

Based on USA Financial Formulas's 13F filing for Q1 2021, filed 6 May 2021.